W STRATEGIES, LLC for ABBVIE INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 20, 2015 | $50,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Oct 20, 2015 | $50,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1101: Viral Hepatitis Testing Act. Increased appropriations for Viral Hepatitis Testing for CDC and VA. Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars, including patent dispute resolution. H.R. 6: 21st Century Cures Act, including inclusion of H.R. 971: OPEN Act. Education about the value of innovative new medicines. Education about the 340(b) program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Copyright/Patent/Trademark CPT
H.R. 9: Innovation Act, including proposed changes to the Inter Partes Review (IPR) process at the Patent and Trademark Office (PTO).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.